Abstract
Although blood transcriptome has emerged as a powerful resource for studying human diseases, the changes in the blood transcriptome of Alzheimer's disease (AD) patients are poorly understood. We conducted transcriptome profiling of 422 participants (208 normal controls and 214 patients with AD) from the Hong Kong Chinese population. WGCNA (weighted correlation network analysis) was performed to construct a co-expression network to identify modules associated with AD and AD-associated biomarkers. Co-expression modules exerting significant association with AD and AD plasma biomarkers (e.g., Aβ and NFL) were identified. Pathway enrichment analysis suggested their possible involvement in specific biological pathways. Motif analysis further revealed the potential mechanisms that driving the observed blood transcriptomic changes observed in AD. The co-expression network analysis of the AD blood transcriptome changes may facilitate a better understanding of AD progression, as well as the identification of potential targets for disease intervention and monitoring.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Alzheimer's & dementia : the journal of the Alzheimer's Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
